BackAbattis Bioceuticals Overview

Abattis Bioceuticals Minority Interest

Latest minority interest for ATTBF: $-410K.

Get informed when a big investor buys or sells

+ Follow
Minority Interest
$-410089.00
↑ 4.86% YoYΔ $-18995.00 vs prior year quarter

Peer average

Loading

Abattis Bioceuticals Minority Interest History

Loading

Abattis Bioceuticals vs. peers: Minority Interest Comparison

Loading

Abattis Bioceuticals Minority Interest Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Abattis Bioceuticals (ATTBF) FAQ

As of the most recent data (September 2019), ATTBF shows a minority interest of $-410K. That compares with $-390K in the prior-year period — down 4.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, ATTBF's minority interest is now $-410K (was $-390K) — a 4.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Abattis Bioceuticals is outperforming or lagging.

Tracking ATTBF's minority interest over time shows whether Abattis Bioceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $-410K That compares with $-390K in the prior-year period — down 4.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this minority interest page, Stockcircle has Abattis Bioceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect minority interest (currently $-410K) with ownership activity and broader fundamentals.

Abattis Bioceuticals's minority interest is $-410K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.